Clinical Trial for Dry Eye Disease

What is Dry Eye Disease (DED)?

Dry eye is a disease of the front of the eye, whereas a disruption in our normal tear production and maintenance occurs. There are two main types of dry eye: aqueous deficient dry eye and evaporative dry eye   

Aqueous deficient dry eye occurs when too little tears are produced by the lacrimal gland located below our eyebrow. When we don’t have adequate aqueous tear production, our ocular surface becomes rough, causing burning, gritty, and scratchy eyes. Wearing contact lenses or having a history of previous eye surgery can contribute to this type of dry eye.  

Evaporative dry eye, also known as meibomian gland dysfunction (MGD), stems from the clogging of the meibomian glands inside of our eyelids. Our meibomian glands secrete meibum, the lipid or oily layer of the tear film. This tear layer helps to keep the other layers of the tear film in place. When our meibomian glands are clogged, our tears can evaporate easily, causing irritation.  

 

Signs & Symptoms

  • Redness
  • Watering
  • Burning
  • Blurry vision
  • Decreased tolerance and discomfort when wearing contact lenses.

 

General study information

This study is intended for people who have the signs and symptoms of Dry Eye Disease. Common symptoms include eye dryness, eye discomfort, visual disturbance, damage to the surface of the ey, burning, stinging, itching, grittiness, scratchiness and tired eye sensation. Symptoms can affect one or both eyes and may be more bothersome later in the day or worsened by environmental factors like wind or air-conditioning.

Purpose & Importance

The purpose of this study is to evaluate how safe and effective an investigational eye drop is compared to a vehicle (solution without the active ingredient) eye drop and how well it will work to treat the signs and symptoms of Dry Eye Disease.

Things to Consider

  • You will have access to clinical study experts that can answer any questions you have throughout the entire journey.
  • Your ocular and systemic health will be closely monitored over the course of the study.
  • Our team has a strong background in Dry Eye Disease (DED) and investigational eye drop clinical trials.

More Information about this Dry Eye Disease Clinical Study

We’re conducting a clinical study to evaluate an investigational eye drop for signs and symptoms of Dry Eye Disease (DED).

Condition

Dry Eye Disease Icon

Investigational eye drop study for Dry Eye Disease

Study Status

Icon for study status

Currently Enrolling

Study Length

This study includes 4 visits over approximately 3 weeks.

Compensation

Complete 4 visits, and you may be compensated up to $700 for your time.

Current Locations

Icon for current locations

This study is taking place at clinics throughout the United States.

Upcoming Locations

Icon for upcoming locations

We are adding new locations for this study regularly. Please fill out the form below to learn more.

Contact us and see if this study is right for you!

Key Requirements

Key Inclusion Criteria

  • Men and women 18 years or older at the time of screening.
  • Have a history of Dry Eye Disease, either clinician-diagnosed or patient-reported, within six months prior to the screening visit.
  • Have used or desired to use artificial tears for Dry Eye Disease symptoms within six months prior to the screening visit.

Key Exclusion Criteria

  • No contact lenses within 7 days of the study and for the duration of the study.
  • Any ocular surgery or ocular procedures within 6 months of visit 1.
  • Other medications and conditions may be exclusionary as well.
  • Any LASIK surgery in the last 12 months.